Benevira, Inc.
Benevira is a global, privately owned synthetic biology company focused on developing sustainable antiviral treatments to protect against viral infections. The company aims to address the challenges of evolving viruses by targeting viral evolutionary bottlenecks, and is dedicated to supplying antivirals globally. Benevira's mission is to develop therapeutics and prophylactics for various viral indications, including SARS-CoV-2, HPV, RSV, MERS, Variola, and Influenza, with the potential for broad-spectrum antivirals.
Industries
Nr. of Employees
small (1-50)
Benevira, Inc.
Products
Lead SARS‑CoV‑2 antiviral candidate (preclinical)
A preclinical antiviral candidate developed to target functional viral components unlikely to evolve; reported in vitro efficacy against multiple SARS‑CoV‑2 variants and favorable tolerability in an animal model.
Lead SARS‑CoV‑2 antiviral candidate (preclinical)
A preclinical antiviral candidate developed to target functional viral components unlikely to evolve; reported in vitro efficacy against multiple SARS‑CoV‑2 variants and favorable tolerability in an animal model.
Services
Synthetic biology-driven antiviral discovery
Discovery services using synthetic biology and computational design to identify antiviral candidates that target conserved viral elements.
Preclinical efficacy and safety testing
In vitro and in vivo preclinical testing services to evaluate antiviral efficacy and tolerability prior to clinical development.
Formulation development and finished-product development
Formulation and product development for finished-dose antiviral products intended for self-administration.
Biologics and therapeutic manufacturing
Development and manufacture of biologics, therapeutics, and consumer health products from internal pipeline efforts.
Synthetic biology-driven antiviral discovery
Discovery services using synthetic biology and computational design to identify antiviral candidates that target conserved viral elements.
Preclinical efficacy and safety testing
In vitro and in vivo preclinical testing services to evaluate antiviral efficacy and tolerability prior to clinical development.
Formulation development and finished-product development
Formulation and product development for finished-dose antiviral products intended for self-administration.
Biologics and therapeutic manufacturing
Development and manufacture of biologics, therapeutics, and consumer health products from internal pipeline efforts.
Expertise Areas
- Synthetic biology
- Antiviral drug discovery
- Preclinical development and testing
- AI-driven computational design
Key Technologies
- Synthetic biology methods
- AI-driven computational design
- Cell-based antiviral assays
- Animal model preclinical testing